Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ubix Therapeutics, Inc.

Clinical trials sponsored by Ubix Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill takes on tough blood cancers in first human trial Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New pill takes on tough blood cancers in first human trial

Disease control Recruiting now

This early-phase trial tests an experimental oral drug called UBX-303061 in 94 adults with B-cell blood cancers (like certain lymphomas and leukemias) that have come back or not responded to at least two prior treatments. The main goals are to check safety, find the right dose, a…

Phase 1 • Sponsor: Ubix Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC